Document Detail


Valiant thoracic stent-graft deployed with the new captivia delivery system: procedural and 30-day results of the valiant captivia registry.
MedLine Citation:
PMID:  22545887     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abstract Purpose: To evaluate procedural and 30-day outcomes of thoracic endovascular aortic repair (TEVAR) employing the Valiant Thoracic Stent Graft with the Captivia Delivery System. Methods: Enrollment in the study ( www.ClinicalTrials.com identifier NCT01181947) included all eligible patients implanted with the Valiant Captivia System retrospectively and prospectively at 15 sites in Europe and Turkey between October 2009 and June 2010. In the 100 treated patients (81 men; mean age 64.6±12.0 years, range 25-87), indications included descending thoracic aortic aneurysm (TAA, 49.0%) and aortic dissection (42.0%). Results: Technical success was 100.0%, with no misaligned deployments or aortic perforations. Mean follow-up was 68.9±34.9 days (range 20-147, median 61). The 30-day rate of all-cause mortality was 4.0% (all 4 cases procedure-related, 3 device-related). Retrograde type A dissection occurred in 2 patients. The only conversion to open surgery was successful in a patient experiencing intraoperative aneurysm rupture. Stroke occurred in 4 (4.0%) patients and paraplegia in 1 (1.0%). Among 66 patients with 30-day imaging studies evaluable for endoleak, 4 (6.1%) had type I and 7 (10.6%) had type II endoleak; there were no types III or IV. Within 30 days, no secondary endovascular procedures were required due to endoleak. One patient with type II endoleak died 3 weeks postimplantation before scheduled embolization. Conclusion: In this analysis of procedural and 30-day results, the high technical success and clinical outcome rates showed that the Valiant Thoracic Stent Graft with the new Captivia Delivery System has promising capacity to treat a variety of thoracic aortic conditions in a range of anatomies.
Authors:
Robin H Heijmen; Matt M Thompson; Rossella Fattori; Yigit Goktay; Omke E Teebken; Karl Heinz Orend
Related Documents :
22743877 - Single-surgeon experience of 87 buccal mucosal graft harvests.
11935057 - Long-term disability after first-ever stroke and related prognostic factors in the pert...
17425487 - Desmoteplase in the treatment of acute ischemic stroke.
25101227 - Adherence to an overweight and obesity treatment: how to motivate a patient?
11591557 - Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in ast...
16327297 - Uterus-sparing vaginal surgery of genitourinary prolapse employing biocompatible material.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists     Volume:  19     ISSN:  1545-1550     ISO Abbreviation:  J. Endovasc. Ther.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-05-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100896915     Medline TA:  J Endovasc Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  213-25     Citation Subset:  IM    
Affiliation:
1  Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current evidence is insufficient to define an optimal threshold for intervention in isolated type II...
Next Document:  In situ laser fenestration for revascularization of the left subclavian artery during emergent thora...